1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, November 2014 (p9)

Biological Therapy Analysis & Statistics, November 2014 (p9)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

241-270 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

uniQure NV - Product Pipeline Review - 2014

uniQure NV - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • November 2014
  • by Global Markets Direct

uniQure NV - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘uniQure NV - Product Pipeline Review - 2014’, provides an overview of the uniQure NV’s pharmaceutical research and ...

  • Industries : Research and Development, Biological Therapy
  • Countries : World
Gamida Cell Ltd. - Product Pipeline Review - 2014

Gamida Cell Ltd. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • November 2014
  • by Global Markets Direct

Gamida Cell Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Gamida Cell Ltd. - Product Pipeline Review - 2014’, provides an overview of the Gamida Cell Ltd.’s pharmaceutical ...

  • Industries : Pathology
  • Countries : Europe, World
Kolon Life Science, Inc. - Product Pipeline Review - 2014

Kolon Life Science, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • November 2014
  • by Global Markets Direct

Kolon Life Science, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Kolon Life Science, Inc. - Product Pipeline Review - 2014’, provides an overview of the Kolon Life Science, ...

  • Countries : World
Global Antisense and RNAi Therapeutics Market 2015-2019

Global Antisense and RNAi Therapeutics Market 2015-2019

  • $ 2 500
  • Industry report
  • November 2014
  • by Infiniti Research Limited

About Antisense and RNAi Therapeutics Antisense and RNAi therapeutics are new innovative therapeutics options that are used in the treatment of serious chronic and rare diseases. RNAi is a RNA-based gene ...

  • Industries : Biological Therapy, Therapy, Pharmaceutical
  • Countries : World
PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy

PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy

  • $ 2 995
  • Industry report
  • November 2014
  • by Global Data

PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy Summary GlobalData’s report "PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy", provides strategic analysis of the global stem cells ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : United States
Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type, Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019

Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type, Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019

  • $ 4 650
  • Industry report
  • November 2014
  • by MarketsandMarkets

Developing markets such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations. The report segments the global SUB market by ...

  • Industries : Biotechnology, Biopharmaceutical
  • Countries : World, Europe, North America
Wounds - Pipeline Review, H2 2014

Wounds - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Wounds - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Wounds - Pipeline Review, H2 2014’, provides an overview of the Wounds’s therapeutic pipeline. This report provides comprehensive ...

  • Industries : Pharmaceutical, Pathology, Drug and Medication
  • Countries : United States
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2014

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2014’, provides an overview of ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Applied Genetic Technologies Corporation - Product Pipeline Review - 2014

Applied Genetic Technologies Corporation - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • October 2014
  • by Global Markets Direct

Applied Genetic Technologies Corporation - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Applied Genetic Technologies Corporation - Product Pipeline Review - 2014’, provides an ...

  • Industries : Genomics
  • Countries : United States
Asia-Pacific Tissue Engineered - Skin Substitutes Market Outlook to 2020

Asia-Pacific Tissue Engineered - Skin Substitutes Market Outlook to 2020

  • $ 3 000
  • Industry report
  • October 2014
  • by Global Data

Asia-Pacific Tissue Engineered - Skin Substitutes Market Outlook to 2020 Summary GlobalData’s new report, "Asia-Pacific Tissue Engineered - Skin Substitutes Market Outlook to 2020", provides key market ...

  • Industries : Medical Equipment and Supply, Medical Devices
  • Countries : Asia
Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options

Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options

  • $ 4 995
  • Industry report
  • October 2014
  • by GBI Research

Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options Summary GBI Research, a leading business ...

  • Industries : Pathology, Pharmaceutical
  • Countries : World
Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2014

Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • October 2014
  • by Global Data

Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2014" provides data on the Wiskott-Aldrich ...

  • Industries : Drug Discovery and Development, Pathology, Pharmaceutical, Therapy
  • Countries : World
Traumatic Brain Injury - Pipeline Review, H2 2014

Traumatic Brain Injury - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Traumatic Brain Injury - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Traumatic Brain Injury - Pipeline Review, H2 2014’, provides an overview of the Traumatic Brain Injury’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Ischemic Stroke - Pipeline Review, H2 2014

Ischemic Stroke - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Ischemic Stroke - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Ischemic Stroke - Pipeline Review, H2 2014’, provides an overview of the Ischemic Stroke’s therapeutic pipeline. This ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Lysosomal Storage Disorder - Pipeline Review, H2 2014

Lysosomal Storage Disorder - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Lysosomal Storage Disorder - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Lysosomal Storage Disorder - Pipeline Review, H2 2014’, provides an overview of the Lysosomal Storage Disorder’s ...

  • Industries : Pharmaceutical, Pathology, Research and Development
  • Countries : United States
Scar - Pipeline Review, H2 2014

Scar - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Scar - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Scar - Pipeline Review, H2 2014’, provides an overview of the Scar’s therapeutic pipeline. This report provides comprehensive information ...

  • Industries : Pharmaceutical, Pathology
  • Countries : United States
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2014

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2014’, provides an overview of the B-Cell ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014’, provides an overview of the ...

  • Industries : Biological Therapy, Blood Supply, Tissue Banking and Transplantation, Biotechnology, Healthcare, Pathology
  • Countries : United States
Multiple Myeloma (Kahler%s Disease) Global Clinical Trials Review, H2, 2014

Multiple Myeloma (Kahler%s Disease) Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • October 2014
  • by Global Data

Multiple Myeloma (Kahler's Disease) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Multiple Myeloma (Kahler's Disease) Global Clinical Trials Review, H2, 2014" provides ...

  • Industries : Pathology, Pharmaceutical, Drug Discovery and Development, Therapy
  • Countries : World
Sylentis S.A. - Product Pipeline Review - 2014

Sylentis S.A. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • October 2014
  • by Global Markets Direct

Sylentis S.A. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Sylentis S.A. - Product Pipeline Review - 2014’, provides an overview of the Sylentis S.A.’s pharmaceutical research ...

  • Industries : General Medicine and Specialty Medicine, Research and Development, Pathology
  • Countries : World
Global Biologic Therapeutics Market 2014-2018

Global Biologic Therapeutics Market 2014-2018

  • $ 3 500
  • Industry report
  • October 2014
  • by Infiniti Research Limited

About Biologic Therapeutics Biologic therapeutics include virus, therapeutic serum, toxin, allergenic product, antitoxin, blood component or derivative, vaccine, blood, protein (except any chemically synthesized ...

  • Industries : Pharmaceutical, Biopharmaceutical, Biotechnology, Therapy, Drug and Medication, Pathology
  • Countries : World
Cell Expansion Market by Product (Reagent, Media, Serum, Bioreactors, Centrifuge), Cell Type (human, animal), Application (Stem Cell Research, Regenerative Medicine, Clinical Diagnostics), End User (Hospital, Biotechnology, Cell Bank) - Forecast to 2019

Cell Expansion Market by Product (Reagent, Media, Serum, Bioreactors, Centrifuge), Cell Type (human, animal), Application (Stem Cell Research, Regenerative Medicine, Clinical Diagnostics), End User (Hospital, Biotechnology, Cell Bank) - Forecast to 2019

  • $ 4 650
  • Industry report
  • October 2014
  • by MarketsandMarkets

The global cell expansion market is expected to reach $14.8 billion by 2019 from $6.0 billion in 2014, growing at a CAGR of 19.7% from 2014 to 2019. The global cell expansion market is categorized on the ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : World
NDDS in Cancer Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

NDDS in Cancer Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

  • $ 4 795
  • Industry report
  • October 2014
  • by Transparency Market Research

This study on novel drug delivery systems (NDDS) in cancer therapy comprises study of technologies such as embolization devices, liquid embolics and nanoparticles that offer unique approaches in cance ...

  • Industries : Biological Therapy
  • Countries : World
TVAX Biomedical, Inc. - Product Pipeline Review - 2014

TVAX Biomedical, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • October 2014
  • by Global Markets Direct

TVAX Biomedical, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘TVAX Biomedical, Inc. - Product Pipeline Review - 2014’, provides an overview of the TVAX Biomedical, Inc.’s ...

  • Industries : Research and Development, Biopharmaceutical
  • Countries : World
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014’, provides ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Mycosis Fungoides - Pipeline Review, H2 2014

Mycosis Fungoides - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Mycosis Fungoides - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Mycosis Fungoides - Pipeline Review, H2 2014’, provides an overview of the Mycosis Fungoides’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
TheraDiag SA - Product Pipeline Analysis, 2014 Update

TheraDiag SA - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • October 2014
  • by Global Data

Summary Theradiag SA (Theradiag) is a biotechnology company. The company develops, manufactures, and markets in-vitro diagnostics. It offers product for the diagnostics of auto-immune diseases, allergies ...

  • Industries : Pathology, Diagnostics, Diagnostics
  • Countries : South Africa, Saudi Arabia
Stem Cell Therapeutics Markets

Stem Cell Therapeutics Markets

  • $ 3 995
  • Industry report
  • October 2014
  • by Kalorama Information

There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. ...

  • Industries : Pathology, Biological Therapy, Pharmaceutical, Biotechnology
  • Countries : United States
Analysis of the Global Stem Cell Market

Analysis of the Global Stem Cell Market

  • $ 6 000
  • Industry report
  • October 2014
  • by Frost & Sullivan

The key to Transforming Future of Diagnostic and Therapeutic Medicine This study investigates the global stem cell market for the period 2013 to 2018. The geographic regions covered in the study are the ...

  • Industries : Biological Therapy
  • Countries : South Korea, India, Singapore
Molecular Diagnostics Partnering Terms and Agreements

Molecular Diagnostics Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • October 2014
  • by Currentpartnering

Summary The Molecular Diagnostics Partnering Terms & Agreements provides comprehensive understanding and unprecedented access to the molecular diagnostics partnering deals and agreements entered into by ...

  • Industries : Pharmaceutical, Pathology, Healthcare, Diagnostics, Diagnostics, General Medicine and Specialty Medicine, Biotechnology, Medical Devices, Therapy
  • Countries : United States, North America

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.